Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2025-12-25 @ 8:23 PM
Study NCT ID:
NCT05872269
Status:
RECRUITING
Last Update Posted:
2024-02-07
First Post:
2023-05-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities
Sponsor:
Zydus Lifesciences Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07-20
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06-10
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-13
First Submit QC Date:
None
Study First Post Date:
2023-05-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-03
Last Update Post Date:
2024-02-07
Last Update Post Date Type:
ACTUAL